Responsiveness of α2-adrenoceptor/I1-imidazoline receptor in the rostral ventrolateral medulla to cardiovascular regulation is enhanced in conscious spontaneously hypertensive rat

Clinical and Experimental Hypertension : CHE
M YamazatoYusuke Ohya

Abstract

Stimulation of α2-adrenoceptor/I1-imidazoline receptors in the rostral ventrolateral medulla decreases the blood pressure via sympathoinhibition. However, alteration of receptor responses in genetically hypertensive rats remains unclear. We examined cardiovascular responses of α2-adrenoceptor/I1-imidazoline receptor agonist and antagonists microinjected into the rostral ventrolateral medulla of conscious spontaneously hypertensive rats and normotensive Wistar Kyoto rats. Injection of 2-nmol clonidine-an α2-adrenoceptor/I1-imidazoline receptor agonist-unilaterally into the rostral ventrolateral medulla decreased the blood pressure, heart rate, and renal sympathetic nerve activity; the responses were significantly enhanced in spontaneously hypertensive rats than in Wistar Kyoto rats. Co-injection of 2-nmol 2-methoxyidazoxan (a selective α2-adrenoceptor antagonist) or 2-nmol efaroxan (an I1-receptor antagonist) with 2 nmol of clonidine attenuated the hypotensive and bradycardic effects of clonidine-only injection. Injection of 2-methoxyidazoxan alone increased the blood pressure and heart rate in spontaneously hypertensive rats, but not in Wistar Kyoto rats. These results suggest enhanced responsiveness of α2-adrenoceptor/I1-imida...Continue Reading

References

Mar 1, 1989·Journal of Cardiovascular Pharmacology·S YamadaE Hayashi
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Aug 1, 1995·Clinical and Experimental Hypertension : CHE·M TozawaK Fukiyama
Jan 1, 1993·Annual Review of Pharmacology and Toxicology·R R RuffoloJ P Hieble
Jan 1, 1997·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·P ErnsbergerR J Koletsky
Jun 1, 1997·The Journal of Clinical Investigation·H TeruyaK Fukiyama
Dec 31, 1997·The American Journal of Physiology·P G Guyenet
Dec 29, 2000·Hypertension Research : Official Journal of the Japanese Society of Hypertension·A SakimaK Fukiyama
Nov 14, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·M YamazatoK Fukiyama
Sep 7, 2002·Hypertension·Valin RejaPaul M Pilowsky
May 9, 2007·The Journal of Clinical Hypertension·Domenic A Sica
Jun 22, 2007·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Wei-Zhong WangWei Wang
Aug 11, 2015·Journal of Advanced Research·Noha N Nassar, Abdel A Abdel-Rahman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.